INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

66,016 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
10
GB
Gordon William BDirector
DUOLDuolingo, Inc.
Open-market sale · 10b5-1 plan
SELL$40K
300 sh
Nov 2, 2026Nov 4, 2026
Page 66 of 1651
← PrevNext →
traded Nov 2, 2026
+2d
SEC Form 4

Evidence

10
BJ
Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO
VRSNVERISIGN INC/CA
Open-market sale · 10b5-1 plan
SELL$37K
120 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

10
AR
Anderson RaymondDirector
MNPRMonopar Therapeutics
Option exercise · 10b5-1 plan
M$52K
1,740 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

10
CE
Cowan ElviaSVP, Finance & CAO
PCVXVaxcyte, Inc.
Open-market sale · 10b5-1 plan
SELL$147K
2,414 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

10
BJ
Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO
VRSNVERISIGN INC/CA
Open-market sale · 10b5-1 plan
SELL$37K
120 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

10
BJ
Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO
VRSNVERISIGN INC/CA
Open-market sale · 10b5-1 plan
SELL$12K
40 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

10
AR
Anderson RaymondDirector
MNPRMonopar Therapeutics
Open-market sale · 10b5-1 plan
SELL$14K
200 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
MT
Moskoff Gregory TMD,Controller and CAO
FDSFACTSET RESEARCH SYSTEMS INC
Grant or award
A—
1,355 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
IM
Isely Raquel M.13D Group Member
NGVCNatural Grocers by Vitamin Cottage, Inc.
Tax withholding
F$33K
1,147 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
TG
Tatusko Michael GSenior Vice President
GVAGRANITE CONSTRUCTION INC
Tax withholding
F$23K
171 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

9
MO
Mooney Kyle OwenSVP - Chief Operating Officer
MSBIMidland States Bancorp, Inc.
Tax withholding
F$21K
645 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

9
SR
Shrewsbury RondaDirector
SRCE1ST SOURCE CORP
Grant or award
A$16K
181 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

9
AK
Anderson-Copperman KristaDirector
ASANAsana, Inc.
Grant or award
A—
1,575 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
PC
Pussinen CynthiaDirector, Chief Executive Officer
ESLAEstrella Immunopharma, Inc.
Grant or award
A—
1.00M sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
HM
Holmes John McClain IIIDirector
GATXGATX CORP
Grant or award
A$26K
142 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
PS
Palatnik Kevin S.Director
LTRXLANTRONIX INC
Option exercise
M—
8,541 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
DN
Derhacobian NarbehDirector
LTRXLANTRONIX INC
Option exercise
M—
8,541 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
VJ
Vassil JonathanChief Revenue Officer
TOSTToast, Inc.
Open-market sale · 10b5-1 plan
SELL$67K
1,951 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$185K
6,995 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
RV
Ramnath VidyaSenior VP &CMO
EMREMERSON ELECTRIC CO
Tax withholding
F$43K
259 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

9
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
7,439 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
BM
Berry Jason MEVP & Chief Operating Officer
ALKALASKA AIR GROUP, INC.
Tax withholding
F$9,600
261 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

9
OK
Ozark Timothy KDirector
SRCE1ST SOURCE CORP
Grant or award
A$19K
215 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

9
PE
Pershing John EChief Human Resources Officer
BURLBurlington Stores, Inc.
Grant or award
A—
731 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
HF
Hassan FredDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Grant or award
A—
156.7K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
MA
Merriman Dwight ADirector
MDBMongoDB, Inc.
Open-market sale · 10b5-1 plan
SELL$411K
1,200 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
BA
Boland Julie ADirector
DEDEERE & CO
Grant or award
A—
92 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
AD
Aigotti DianeDirector
GATXGATX CORP
Grant or award
A$13K
72 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
WJ
Warren JoshuaEVP, Chief Financial Officer
FDSFACTSET RESEARCH SYSTEMS INC
Grant or award
A—
9,376 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
GR
Garechana RobertDirector
IVTInvenTrust Properties Corp.
Grant or award
A—
1,938 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

9
LM
Latimer Timothy MichaelDirector, Chief Executive Officer
FRVOFervo Energy Co
Grant or award
A—
10.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
BJ
Bausch Shelley JDirector
GATXGATX CORP
Grant or award
A$25K
141 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
PJ
Piazza Nicholas J.Senior VP & CPO
EMREMERSON ELECTRIC CO
Grant or award
A—
5,396 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
CA
Canini Elizabeth A.EVP, Chief Credit Risk Officer
RMRegional Management Corp.
Grant or award
A—
1,275 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
OS
Ozonian StevenDirector
TREELendingTree, Inc.
Option exercise
M—
1,000 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

9
MS
Mitra SabyaschiGroup President
EMREMERSON ELECTRIC CO
Grant or award
A—
4,981 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
SJ
Sordello Steven JDirector
COMPCompass, Inc.
Option exercise
M—
2,419 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
IM
Isely Raquel M.13D Group Member
NGVCNatural Grocers by Vitamin Cottage, Inc.
Option exercise
M—
4,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
EC
Endweiss CharlesVP Financial Planning Analysis
SEERSeer, Inc.
Grant or award
A—
65.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
7,830 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. BUYMTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K